In conclusion, our work suggests that while we can find differences in CLE lesional subtypes, particularly an IFN-γ signature in DLE patients, molecular signatures that center around neutrophilic or monocytic subtypes may be more informative regarding pathobiology and relevant targets for treatment. Here, IFNG is linked to discoid lupus erythematosus.